2026 APR
Are you looking for a high-quality Grapiprant source for your advanced veterinary pain management solutions?
Our European-manufactured Grapiprant provides a targeted, receptor-specific alternative to traditional NSAIDs—delivering clinically demonstrated efficacy with the production reliability of a leading CDMO.
Download our brochure to discover the key benefits of our EP4 antagonist and why Menadiona is the strategic choice for the veterinary industry.